Simulations Plus, Inc. Update: The Company is Being Acquired

If you follow Simulations Plus, Inc. (ticker: SLP), there is major news. The company has officially signed a deal to be acquired. Here is what this means for you.

1. What happened?

Simulations Plus signed an agreement to be bought by an investment firm, Altaris, LLC. Once the deal closes, Simulations Plus will no longer be a public company. Instead, it will become a private subsidiary of Altaris. Altaris plans to combine Simulations Plus with Chemical Computing Group (CCG), a company they already own that specializes in molecular design software.

2. What is the deal worth?

Stockholders will receive $18.50 per share in cash. This price is a 26% premium over the company’s average stock price from the 60 days before the announcement.

3. Why is this happening?

Simulations Plus provides software and consulting that uses AI and advanced modeling to help drug companies simulate development. Leadership believes the industry is moving toward integrated, AI-driven platforms. By joining Altaris and CCG, the company hopes to speed up innovation and offer better tools to its customers. For Altaris, this move consolidates their expertise in healthcare software and computational biology.

4. What does this mean for investors?

• The Payout: If you own SLP stock, you don’t need to do anything. When the deal closes, your shares will be automatically canceled and converted into a cash payment of $18.50 per share.
• The Stock Price: You will likely see the stock price trading very close to the $18.50 offer. The price will now move based on the market’s view of the deal’s timeline and regulatory risks, rather than daily business news.
• No More Earnings Calls: The company has stopped holding quarterly earnings calls. They plan to report their third-quarter fiscal 2026 results on July 9, 2026, only through a press release.

5. Who else is affected?

• Customers: The company says it is "business as usual." They aim to keep software support and consulting services running smoothly during the transition.
• Employees: The headquarters will stay in Research Triangle Park, North Carolina. While the company hasn't provided specific details on internal restructuring, the stated goal is long-term growth and combining technologies.

6. What happens next?

The deal should close in the fourth quarter of 2026, assuming standard conditions are met:

• Shareholder Vote: You will receive a proxy statement with details and will be asked to vote on the merger. Dr. Walter Woltosz, the co-founder and a major shareholder, has already agreed to support the deal.
• Regulatory Approval: Government antitrust authorities must review the deal to ensure it follows competition laws.

7. A final tip for traders

Altaris has already secured the money needed for this acquisition. Because the deal does not depend on future financing, there is a higher level of certainty that the purchase will go through compared to deals that still need to raise cash.

Decision Checklist:

• If you hold the stock: You are essentially waiting for the $18.50 cash payout. The stock will likely trade at a slight discount to this price until the deal closes to account for the time value of money and the small risk that the deal could fall through.
• If you are looking to buy: Understand that the "growth" potential of the stock is now capped at the $18.50 offer price. You are essentially betting on the deal closing successfully.

Disclaimer: I’m just here to help explain the news! I am not a financial advisor, and this isn't investment advice. Always do your own research before making any moves with your money.